Structures by: Siddiqui H. L.
Total: 83
O-Sulfamoylbenzoic acid
C7H7NO4S
Acta Crystallographica Section E (2007) 63, 10 o4117-o4117
a=12.200(4)Å b=15.824(6)Å c=9.012(4)Å
α=90.00° β=100.45(2)° γ=90.00°
<i>N</i>-[2-(Aminocarbonyl)phenyl]-4-hydroxy-2<i>H</i>-1,2-benzothiazine- 3-carboxamide 1,1-dioxide dimethyl sulfoxide solvate
C16H13N3O5S,C2H6OS
Acta Crystallographica Section E (2007) 63, 11 o4215-o4216
a=8.8314(5)Å b=9.1405(5)Å c=24.5041(14)Å
α=90.00° β=96.499(2)° γ=90.00°
4-Hydroxy-4,6a,6b,9,9,12a,14b-heptamethylperhydropicen-3-one hemihydrate
C29H48O2,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 1 o264-o264
a=6.4432(4)Å b=57.477(8)Å c=7.2226(6)Å
α=90.00° β=114.725(5)° γ=90.00°
1-(5a,5b,8,8,11a,13b-Hexamethyleicosahydro-1H-cyclopenta[a]chrysen-3-yl)-1-ethanone
C29H48O
Acta Crystallographica Section E (2008) 64, 4 o723
a=6.581(3)Å b=7.260(4)Å c=27.908(14)Å
α=84.98(2)° β=86.48(3)° γ=64.01(3)°
2-Methyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide
C8H7NO3S
Acta Crystallographica Section E (2008) 64, 4 o724
a=7.463(7)Å b=6.761(6)Å c=8.748(8)Å
α=90.00° β=103.78(3)° γ=90.00°
4-(4-Fluorophenyl)-6-(2-furyl)pyrimidin-2-amine
C14H10FN3O
Acta Crystallographica Section E (2008) 64, 6 o963
a=11.629(4)Å b=5.992(3)Å c=16.389(6)Å
α=90.00° β=97.69(2)° γ=90.00°
<i>N</i>'-(2,4-Dinitrophenyl)acetohydrazide
C8H8N4O5
Acta Crystallographica Section E (2008) 64, 8 o1441
a=4.8585(4)Å b=10.7703(8)Å c=19.1059(14)Å
α=90.00° β=90.00° γ=90.00°
N-Chloromethylsaccharin
C8H6ClNO3S
Acta Crystallographica Section E (2007) 63, 10 o4116-o4116
a=9.208(5)Å b=8.643(4)Å c=12.458(6)Å
α=90.00° β=107.46(2)° γ=90.00°
(2E)-3-(4-Chlorophenyl)-1-(1<i>H</i>-pyrrol-2-yl)prop-2-en-1-one
C13H10ClNO
Acta Crystallographica Section E (2008) 64, 5 o867-o868
a=13.0401(7)Å b=5.6326(3)Å c=15.6857(8)Å
α=90.00° β=94.979(3)° γ=90.00°
Methyl 3-oxo-2,3-dihydro-1,2-benzothiazole-2-acetate 1,1-dioxide
C10H9NO5S
Acta Crystallographica Section E (2008) 64, 5 o859
a=7.765(3)Å b=8.496(3)Å c=8.776(4)Å
α=104.39(2)° β=100.58(2)° γ=94.30(2)°
Tetraaquabis(2-sulfamoylbenzoato)manganese(II)
C14H20Mn1N2O12S2
Acta Crystallographica Section E (2008) 64, 10 m1293-m1294
a=15.2442(4)Å b=8.2835(2)Å c=7.9188(2)Å
α=90° β=99.9710(10)° γ=90°
3-Benzylamino-1,2-benzisothiazole 1,1-dioxide
C14H12N2O2S
Acta Crystallographica Section E (2007) 63, 10 o4001
a=7.061(3)Å b=7.052(2)Å c=24.959(11)Å
α=90.00° β=93.997(18)° γ=90.00°
2-Methyl-2H-1,2-benzothiazin-4(3H)-one 1,1-dioxide
C9H9NO3S
Acta Crystallographica Section E (2007) 63, 12 o4585-o4585
a=6.778(5)Å b=8.634(6)Å c=15.704(10)Å
α=90.00° β=90.00° γ=90.00°
1-Oxo-N-phenylisoindoline-2-carboxamide
C15H12N2O2
Acta Crystallographica Section E (2007) 63, 12 o4728-o4728
a=12.905(4)Å b=5.6190(10)Å c=17.161(6)Å
α=90.00° β=102.228(17)° γ=90.00°
<i>N</i>-Butyl-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C14H18N2O4S
Acta Crystallographica Section E (2008) 64, 7 o1213-o1214
a=10.233(2)Å b=14.780(4)Å c=10.365(5)Å
α=90.00° β=108.79(2)° γ=90.00°
Methyl N-saccharinylmethyl sulfide
C9H9NO3S2
Acta Crystallographica Section E (2008) 64, 10 o1897
a=7.550(3)Å b=17.332(8)Å c=9.455(3)Å
α=90.00° β=124.26(2)° γ=90.00°
4-Hydroxy-3-carbomethoxy-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C10H9NO5S
Acta Crystallographica Section E (2008) 64, 10 o1922
a=7.777(2)Å b=10.932(4)Å c=12.890(4)Å
α=105.569(16)° β=94.588(15)° γ=97.763(16)°
<i>N</i>-Methyl-1-oxoisoindoline-2-carboxamide monohydrate
C10H10N2O2,H2O
Acta Crystallographica Section E (2008) 64, 5 o786
a=7.4264(4)Å b=29.0200(16)Å c=4.8864(2)Å
α=90.00° β=108.266(3)° γ=90.00°
N-[2-(Aminocarbonyl)phenyl]-4-hydroxy-2-methyl-2H-1,2-benzothiazine- 3-carboxamide-1,1-dioxide dimethyl sulfoxide solvate
C17H15N3O5S,C2H6OS
Acta Crystallographica Section E (2007) 63, 2 o900-o901
a=8.4973(2)Å b=10.1959(4)Å c=12.0545(4)Å
α=92.132(2)° β=101.540(2)° γ=95.550(2)°
1-Oxoisoindoline-2-carboxamide
C9H8N2O2
Acta Crystallographica Section E (2008) 64, 3 o626
a=3.9839(3)Å b=7.8732(8)Å c=25.651(2)Å
α=90° β=90° γ=90°
Methyl 4-acetoxy-2-methyl-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C13H13NO6S
Acta Crystallographica Section E (2008) 64, 3 o594
a=6.8917(5)Å b=24.1814(17)Å c=8.2861(5)Å
α=90.00° β=97.876(4)° γ=90.00°
1-(4-Hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)ethanone
C11H11NO4S
Acta Crystallographica Section E (2008) 64, 5 o788
a=6.85230(10)Å b=8.3222(2)Å c=10.4880(2)Å
α=72.1321(11)° β=77.9619(12)° γ=80.0360(12)°
2-[(3,4-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=11.597(9)Å b=7.450(3)Å c=16.324(13)Å
α=90.00° β=97.29(3)° γ=90.00°
2-[(2,6-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=7.968(3)Å b=8.509(5)Å c=21.510(11)Å
α=84.30(2)° β=82.46(3)° γ=88.66(3)°
2-[(2,3-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=12.842(7)Å b=15.153(9)Å c=7.572(4)Å
α=90.00° β=91.16(4)° γ=90.00°
(2E)-3-(2-chloro-6-methylquinolin-3-yl)-1-(5-iodothiophen-2-yl)prop-2-en-1-one,
C17H11ClINOS
Acta Crystallographica Section C (2008) 64, 10 o547-o549
a=17.112(6)Å b=7.636(3)Å c=13.174(5)Å
α=90.00° β=111.29(2)° γ=90.00°
(2E)-3-(2-chloro-6-methylquinolin-3-yl)-1-(5-methylfuran-2-yl)prop-2-en-1-one
C18H14ClNO2
Acta Crystallographica Section C (2008) 64, 10 o547-o549
a=36.228(10)Å b=7.372(3)Å c=11.214(5)Å
α=90.00° β=99.70(2)° γ=90.00°
N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C16H13ClN2O4S
Acta Crystallographica Section C (2008) 64, 1 o4-o6
a=7.970(5)Å b=10.945(6)Å c=11.133(7)Å
α=60.61(3)° β=69.81(3)° γ=86.32(2)°
N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C16H13ClN2O4S
Acta Crystallographica Section C (2008) 64, 1 o4-o6
a=7.750(2)Å b=28.588(7)Å c=7.5190(10)Å
α=90.00° β=106.630(12)° γ=90.00°
2-[N-(2-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=15.734(9)Å b=10.614(6)Å c=7.717(3)Å
α=90.00° β=90.00° γ=90.00°
2-[N-(4-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=7.435(2)Å b=16.006(6)Å c=22.061(7)Å
α=90.00° β=90.00° γ=90.00°
3-[(Methylcarbamoyl)amino]-1<i>H</i>-isoindolium chloride
C10H12N3O,Cl
Acta Crystallographica Section E (2009) 65, 3 o448
a=7.1171(5)Å b=7.7900(6)Å c=10.3033(8)Å
α=89.484(3)° β=69.997(2)° γ=74.613(4)°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>'-(2- thienylmethylidene)acetohydrazide
C18H17N5O3S2
Acta Crystallographica Section E (2010) 66, 6 o1265-o1266
a=18.5474(2)Å b=11.6670(5)Å c=8.4783(7)Å
α=90.00° β=90.00° γ=90.00°
4-Hydroxy-3-(3-methoxybenzoyl)-2-[(3-methoxybenzoyl)methyl]-2<i>H</i>-1,2- benzothiazine 1,1-dioxide
C25H21NO7S
Acta Crystallographica Section E (2010) 66, 9 o2314-o2315
a=10.3169(2)Å b=10.6923(3)Å c=11.6867(3)Å
α=115.5965(11)° β=105.8041(14)° γ=97.6128(13)°
(1<i>R</i>,3<i>S</i>)-1,1'-(1,3-Dihydro-2-benzofuran-1,3-diyl)bis(1,3- dimethylurea)
C14H20N4O3
Acta Crystallographica Section E (2009) 65, 1 o42-o43
a=14.6322(6)Å b=9.1014(3)Å c=21.2307(9)Å
α=90° β=90° γ=90°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>'-(3- methoxybenzylidene)acetohydrazide dimethylformamide hemisolvate
C21H21N5O4S,0.5(C3H7NO)
Acta Crystallographica Section E (2011) 67, 1 o216-o217
a=18.3806(5)Å b=8.1155(2)Å c=30.4715(5)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-(2-Chlorobenzylidene)-2-(3,4-dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)acetohydrazide
C20H18ClN5O3S
Acta Crystallographica Section E (2011) 67, 1 o218-o219
a=11.4881(2)Å b=12.7518(3)Å c=15.5690(4)Å
α=71.2778(11)° β=78.6837(13)° γ=70.4911(12)°
2-(2-Oxo-2-phenylethyl)-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C15H11NO4S
Acta Crystallographica Section E (2010) 66, 3 o616
a=8.0730(2)Å b=9.1270(3)Å c=18.0143(6)Å
α=90.00° β=95.4616(18)° γ=90.00°
2-[2-(3-Chlorophenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C15H10ClNO4S
Acta Crystallographica Section E (2010) 66, 3 o617
a=7.7258(4)Å b=9.0780(4)Å c=10.0809(5)Å
α=83.884(3)° β=85.092(3)° γ=87.765(3)°
2-[2-(3-Methoxyphenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C16H13NO5S
Acta Crystallographica Section E (2010) 66, 3 o618
a=8.9824(3)Å b=8.5801(4)Å c=19.5645(7)Å
α=90.00° β=97.942(2)° γ=90.00°
(4-Hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)(3-methoxyphenyl)methanone
C16H13NO5S
Acta Crystallographica Section E (2010) 66, 5 o1021
a=8.1866(3)Å b=7.2431(3)Å c=25.2452(9)Å
α=90.00° β=95.5869(18)° γ=90.00°
Ethyl 5-amino-1-(4-chloro-2-nitrophenyl)-1<i>H</i>-pyrazole-4-carboxylate
C12H11ClN4O4
Acta Crystallographica Section E (2009) 65, 2 o275-o276
a=8.5899(8)Å b=10.2413(9)Å c=15.6633(14)Å
α=90.00° β=96.5415(13)° γ=90.00°
4-(4-Bromophenyl)-6-(4-chlorophenyl)pyrimidin-2-ylamine
C16H11BrClN3
Acta Crystallographica Section E (2009) 65, 2 o390
a=39.343(8)Å b=3.851(2)Å c=22.620(6)Å
α=90.00° β=123.81(2)° γ=90.00°
<i>N</i>-acetonylsaccharin
C10H9NO4S
Acta Crystallographica Section E (2009) 65, 9 o2185
a=7.475(3)Å b=8.975(4)Å c=15.923(7)Å
α=90.00° β=101.028(18)° γ=90.00°
<i>N</i>-(2-Chlorophenyl)-4-hydroxy-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C15H11ClN2O4S
Acta Crystallographica Section E (2009) 65, 9 o2279-o2280
a=10.077(2)Å b=13.818(3)Å c=21.426(4)Å
α=90.00° β=97.070(13)° γ=90.00°
Methyl 2-methyl-4-(oxiran-2-ylmethoxy)-2<i>H</i>-1,2-benzothiazine-3-carboxylate 1,1-dioxide
C14H15NO6S
Acta Crystallographica Section E (2010) 66, 2 o333
a=7.2007(3)Å b=12.8435(6)Å c=15.7820(7)Å
α=90.00° β=96.5250(7)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-(Diethylamino)benzylidene]-4-nitrobenzohydrazide monohydrate
C18H20N4O3,H2O
Acta Crystallographica Section E (2010) 66, 4 o1007-o1008
a=38.3142(12)Å b=7.4563(3)Å c=12.6332(5)Å
α=90.00° β=98.215(2)° γ=90.00°
3-Benzoyl-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C16H13NO4S
Acta Crystallographica Section E (2010) 66, 4 o968
a=6.8342(3)Å b=9.9085(3)Å c=10.7234(4)Å
α=83.257(2)° β=79.481(2)° γ=85.113(2)°
<i>N</i>-Saccharinylmethyl ether
C16H12N2O7S2
Acta Crystallographica Section E (2010) 66, 4 o929
a=8.9317(4)Å b=18.3681(6)Å c=10.1942(5)Å
α=90.00° β=93.517(2)° γ=90.00°
(3-Chlorophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10ClNO4S
Acta Crystallographica Section E (2010) 66, 4 o885
a=4.7151(3)Å b=12.2879(8)Å c=12.5809(6)Å
α=81.375(3)° β=84.463(3)° γ=85.608(3)°
(<i>E</i>)-3-(2-Chloro-6-methyl-3-quinolyl)-1-(2,3-dihydro-1,4-benzodioxin-\ 6-yl)prop-2-en-1-one
C21H16ClNO3
Acta Crystallographica Section E (2010) 66, 4 o744
a=6.370(3)Å b=38.735(9)Å c=7.409(4)Å
α=90.00° β=114.93(2)° γ=90.00°
3-Benzoyl-4-hydroxy-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C15H11NO4S
Acta Crystallographica Section E (2010) 66, 4 o862
a=13.8675(4)Å b=7.6289(2)Å c=25.7553(9)Å
α=90.00° β=102.4519(12)° γ=90.00°
4-Nitro-<i>N</i>'-[(<i>E</i>)-3-pyridylmethylidene]benzohydrazide
C13H10N4O3
Acta Crystallographica Section E (2010) 66, 4 o976
a=14.6158(3)Å b=8.1969(2)Å c=10.3645(2)Å
α=90.00° β=100.6090(10)° γ=90.00°
<i>N</i>'-(3-Methoxybenzylidene)-4-nitrobenzohydrazide monohydrate
C15H13N3O4,H2O
Acta Crystallographica Section E (2010) 66, 4 o977-o978
a=6.7162(3)Å b=7.4929(3)Å c=32.1141(15)Å
α=91.883(2)° β=91.5697(12)° γ=112.753(2)°
(2<i>E</i>)-3-(2-Chloro-6-methyl-3-quinolyl)-1-(1-naphthyl)prop-2-en-1-one
C23H16ClNO
Acta Crystallographica Section E (2010) 66, 4 o761
a=16.919(8)Å b=7.146(3)Å c=14.829(5)Å
α=90.00° β=103.29(2)° γ=90.00°
4-Nitro-<i>N'</i>-[(1<i>E</i>,2<i>E</i>)-3-phenylprop-2-en-1- ylidene]benzohydrazide
C16H13N3O3
Acta Crystallographica Section E (2010) 66, 5 o1022
a=16.4236(17)Å b=5.3360(5)Å c=17.1073(18)Å
α=90.00° β=114.578(5)° γ=90.00°
(<i>E</i>)-3-(3-Chlorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
C16H13ClO2
Acta Crystallographica Section E (2010) 66, 6 o1346-o1347
a=10.3415(6)Å b=3.89380(10)Å c=16.9152(10)Å
α=90.00° β=107.582(2)° γ=90.00°
Isopropyl 2-(3,4-dimethyl-5,5-dioxo-4<i>H</i>-pyrazolo[4,3-<i>c</i>][1,2]benzothiazin- 2-yl)acetate
C16H19N3O4S
Acta Crystallographica Section E (2010) 66, 10 o2630
a=7.6370(2)Å b=8.5412(2)Å c=13.3096(4)Å
α=98.4584(18)° β=97.4870(13)° γ=95.9599(17)°
<i>N</i>'-(2,6-Dichlorobenzylidene)-2-hydroxybenzohydrazide
C14H10Cl2N2O2
Acta Crystallographica Section E (2010) 66, 10 o2603
a=7.5029(6)Å b=23.8363(13)Å c=8.0286(7)Å
α=90.00° β=109.860(6)° γ=90.00°
4-Hydroxy-2-[(4-iodobenzoyl)methyl]-3-(3-methoxybenzoyl)-2<i>H</i>- 1,2-benzothiazine 1,1-dioxide
C24H18INO6S
Acta Crystallographica Section E (2010) 66, 9 o2327
a=9.7392(2)Å b=11.5288(3)Å c=20.4634(4)Å
α=90.00° β=100.5288(11)° γ=90.00°
(2-Bromophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10BrNO4S
Acta Crystallographica Section E (2012) 68, 4 o1247
a=12.0433(4)Å b=8.5491(3)Å c=14.7841(5)Å
α=90.00° β=106.3950(19)° γ=90.00°
<i>N</i>-Benzyl-4-hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1λ^6^,2- benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section E (2012) 68, 6 o1921
a=8.785(3)Å b=9.122(3)Å c=11.425(4)Å
α=66.61(2)° β=87.66(2)° γ=69.38(2)°
2-(<i>N</i>-Cyclohexylcarbamoyl)benzenesulfonamide
C13H18N2O3S
Acta Crystallographica Section E (2012) 68, 2 o370
a=16.1869(5)Å b=10.8467(3)Å c=15.9353(4)Å
α=90.00° β=90.00° γ=90.00°
3-[4-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)phenyl]-2-hydroxy-1-mesitylprop-2-en-1-one hexane hemisolvate
C29H27N3O4S,0.5(C6H14)
Acta Crystallographica Section E (2012) 68, 2 o460-o461
a=7.1772(2)Å b=23.2178(5)Å c=16.7740(4)Å
α=90.00° β=99.5260(10)° γ=90.00°
2-(3-Benzoyl-4-hydroxy-1,1-dioxo-2<i>H</i>-1λ^6^,2-benzothiazin-2-yl)- 1-phenylethanone
C23H17NO5S
Acta Crystallographica Section E (2012) 68, 1 o92
a=7.5458(2)Å b=10.9169(4)Å c=12.0924(4)Å
α=101.920(2)° β=101.423(2)° γ=90.484(2)°
3-[(3-Benzoyl-4-hydroxy-1,1-dioxo-2<i>H</i>-1λ^6^,2-benzothiazin-2- yl)methyl]benzonitrile
C23H16N2O4S
Acta Crystallographica Section E (2012) 68, 1 o91
a=12.2900(2)Å b=24.7970(6)Å c=25.6080(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-[(<i>E</i>)-1-(4-Bromophenyl)ethylidene]-4-hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1,2-benzothiazine-3-carbohydrazide
C18H16BrN3O4S
Acta Crystallographica Section E (2011) 67, 10 o2613
a=14.692(2)Å b=16.562(2)Å c=7.5254(10)Å
α=90.00° β=104.8200(10)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-1-(4-methoxyphenyl)ethanone
C20H19N3O4S
Acta Crystallographica Section E (2012) 68, 2 o458-o459
a=13.862(5)Å b=8.079(2)Å c=17.748(7)Å
α=90.00° β=108.372(18)° γ=90.00°
3,4-Dimethyl-2-(2-oxo-2-phenylethyl)-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazine-5,5-dione
C19H17N3O3S
Acta Crystallographica Section E (2012) 68, 2 o502
a=24.380(6)Å b=11.141(4)Å c=14.996(5)Å
α=90.00° β=120.76(2)° γ=90.00°
2-[2-(3-Chlorophenyl)-2-oxoethyl]-4-hydroxy-3-(3-methoxybenzoyl)- 2<i>H</i>-1λ^6^,2-benzothiazine-1,1-dione
C24H18ClNO6S
Acta Crystallographica Section E (2012) 68, 4 o980-o981
a=10.2562(3)Å b=10.9602(3)Å c=11.3861(4)Å
α=116.5460(15)° β=105.3216(13)° γ=97.2383(14)°
3-[Hydroxy(3-methoxyphenyl)methylidene]-2-(2-oxo-2-phenylethyl)- 3,4-dihydro-2<i>H</i>-1λ^6^,2-benzothiazine-1,1,4-trione
C24H19NO6S
Acta Crystallographica Section E (2012) 68, 4 o978-o979
a=17.9615(5)Å b=11.2633(3)Å c=19.5904(6)Å
α=90.00° β=90.00° γ=90.00°
1-(4-Chlorophenyl)-2-[4-hydroxy-3-(3-methoxybenzoyl)-1,1-dioxo-2<i>H</i>- 1λ^6^,2-benzothiazin-2-yl]ethanone
C24H18ClNO6S
Acta Crystallographica Section E (2012) 68, 4 o1058-o1059
a=7.2656(2)Å b=11.4237(4)Å c=12.8997(5)Å
α=97.147(2)° β=96.934(2)° γ=91.166(2)°
[2-(2,5-Dichlorobenzyl)-4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin- 3-yl](phenyl)methanone
C22H15Cl2NO4S
Acta Crystallographica Section E (2012) 68, 5 o1359
a=12.8172(5)Å b=9.9215(4)Å c=16.7155(5)Å
α=90.000(2)° β=110.511(2)° γ=90.000(2)°
(2-Chlorophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10ClNO4S
Acta Crystallographica Section E (2012) 68, 5 o1326
a=12.1078(6)Å b=8.4057(5)Å c=14.7022(9)Å
α=90.00° β=105.541(3)° γ=90.00°
4-Hydroxy-2-methyl-1,1-dioxo-<i>N</i>-phenyl-2<i>H</i>- 1λ^6^,2-benzothiazine-3-carboxamide
C16H14N2O4S
Acta Crystallographica Section E (2012) 68, 6 o1790
a=10.502(2)Å b=7.649(3)Å c=19.235(4)Å
α=90.00° β=103.395(15)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)acetic acid
C13H13N3O4S
Acta Crystallographica Section E (2012) 68, 6 o1970-o1971
a=10.495(4)Å b=8.415(2)Å c=15.136(6)Å
α=90.00° β=91.034(19)° γ=90.00°
2-[2-(2-Bromophenyl)-2-oxoethyl]-1λ^6^,2-benzothiazole-1,1,3-trione
C15H10BrNO4S
Acta Crystallographica Section E (2012) 68, 6 o1889-o1890
a=7.574(2)Å b=13.903(4)Å c=14.814(4)Å
α=110.574(15)° β=96.936(13)° γ=93.640(14)°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>-(2-fluorobenzyl)acetamide
C20H19FN4O3S
Acta Crystallographica Section E (2012) 68, 8 o2470-o2471
a=27.4331(15)Å b=7.4519(5)Å c=9.2598(6)Å
α=90.00° β=90.00° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>-pyrazolo[4,3- <i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>-(3-methoxybenzyl)acetamide
C21H22N4O4S
Acta Crystallographica Section E (2012) 68, 11 o3064-o3065
a=8.65410(10)Å b=25.8809(3)Å c=18.3892(2)Å
α=90.00° β=92.2080(10)° γ=90.00°
Propan-2-yl 2-(1,1,3-trioxo-2,3-dihydro-1λ^6^,2-benzothiazol-2-yl)acetate
C12H13NO5S
Acta Crystallographica Section E (2012) 68, 9 o2761
a=8.0922(3)Å b=9.2314(4)Å c=17.7414(8)Å
α=90.00° β=100.075(2)° γ=90.00°
Ethyl 2-(3,4-dimethyl-5,5-dioxo-1<i>H</i>,4<i>H</i>- benzo[<i>e</i>]pyrazolo[4,3-<i>c</i>][1,2]thiazin-1-yl)acetate
C15H17N3O4S
Acta Crystallographica Section E (2012) 68, 10 o3010
a=8.3027(2)Å b=8.5915(3)Å c=22.3476(7)Å
α=90.00° β=90.674(2)° γ=90.00°
4-Methyl-3-phenyl-2,4-dihydropyrazolo[4,3-<i>c</i>][1,2]benzothiazine 5,5-dioxide
C16H13N3O2S
Acta Crystallographica Section E (2012) 68, 9 o2615-o2616
a=12.1028(5)Å b=16.3934(7)Å c=7.0962(3)Å
α=90.00° β=90.00° γ=90.00°
2-[2-(2-Chlorophenyl)-2-oxoethyl]-2,3-dihydro-1λ^6^,2-benzothiazole- 1,1,3-trione
C15H10ClNO4S
Acta Crystallographica Section E (2012) 68, 9 o2802
a=7.4933(2)Å b=13.9702(3)Å c=14.5844(3)Å
α=109.0462(14)° β=96.5998(14)° γ=93.4671(11)°